0001005477-01-501242.txt : 20011009 0001005477-01-501242.hdr.sgml : 20011009 ACCESSION NUMBER: 0001005477-01-501242 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010928 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SACANE SCOTT CENTRAL INDEX KEY: 0001160291 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O HIGHLINE MANAGEMENT LLC STREET 2: 888 SEVENTH AVE CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 2126032600 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALLOS THERAPEUTICS CENTRAL INDEX KEY: 0001097264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 541655029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60251 FILM NUMBER: 1748846 BUSINESS ADDRESS: STREET 1: 7000 NORTH BROADWAY STREET 2: SUITE 400 CITY: DENVER STATE: CO ZIP: 80221 BUSINESS PHONE: 3034266262 MAIL ADDRESS: STREET 1: 7000 NORTH BROADWAY STREET 2: SUITE 400 CITY: DENVER STATE: CO ZIP: 80221 SC 13G 1 d01-34738.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 --------------------- SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13D-1(B) AND AMENDMENTS THERETO FILED PURSUANT TO 13D-2(b) (Amendment No. )(1) Allos Therapeutics, Inc. -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 Par Value -------------------------------------------------------------------------------- (Title of Class of Securities) 019777101 -------------------------------------------------------------------------------- (CUSIP Number) September 20, 2001 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) --------------------- Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1 (b) |X| Rule 13d-1 (c) |_| Rule 13d-1 (d) (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilites of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ------------------------- ---------------------------- CUSIP NO. 019777101 13G Page 2 of 5 Pages ------------------------- ---------------------------- -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Scott Sacane -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |X| -------------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES 1,230,000 (as managing member of Highline Management, LLC) --------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY 0 --------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 1,230,000 (as managing member of Highline Management, LLC) --------------------------------------------------------- PERSON 8 SHARED DISPOSITIVE POWER WITH 0 -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,230,000 (as managing member of Highline Management, LLC) -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.36% -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* Other (OO) -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! ------------------------- ---------------------------- CUSIP NO. 019777101 13G Page 3 of 5 Pages ------------------------- ---------------------------- The filing of this statement shall not be construed as an admission that Highline Management, LLC is the beneficial owner of the securities covered by such statement. -------------------------------------------------------------------------- Item 1(a). Name of Issuer: Allos Therapeutics, Inc. -------------------------------------------------------------------------- Item 1(b). Address of Issuer's Principal Executive Offices: 700 North Broadway, Suite 400, Denver, CO 80221 -------------------------------------------------------------------------- Item 2(a). Name of Person Filing: Scott Sacane ("Sacane"), as managing member of Highline Management, LLC ("Highline"), by virtue of Highline's direct beneficial ownership of 1,230,000 shares of the common stock of the Company, par value $0.001 (the "Common Stock"). -------------------------------------------------------------------------- Item 2(b). Address of Principal Business Office, or, if None, Residence: 888 Seventh Avenue, 29th Floor, New York, NY 10106 -------------------------------------------------------------------------- Item 2(c). Citizenship: United States -------------------------------------------------------------------------- Item 2(d). Title of Class of Securities: Common Stock, $.001 Par Value -------------------------------------------------------------------------- Item 2(e). CUSIP NUMBER: 019777101 -------------------------------------------------------------------------- Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person Filing is a: (a) |_| Broker or dealer registered under Section 15 of the Act. (b) |_| Bank as defined in Section 3(a)(6) of the Act. (c) |_| Insurance Company as defined in Section 3(a)(19) of the Act. (d) |_| Investment Company registered under Section 8 of the Investment Company Act. (e) |_| Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940. (f) |_| Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see 13d-1(b)(1)(ii)(F). (g) |_| Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G); see Item 7. (h) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(H). ------------------------- ---------------------------- CUSIP NO. 019777101 13G Page 4 of 5 Pages ------------------------- ---------------------------- Item 4. Ownership. If the percent of the class owned, as of December 31 of the year covered by the statement, or as of the last day of any month described in Rule 13d-1(b)(2), if applicable, exceeds five percent, provide the following information as of that date and identify those shares which there is a right to acquire. (a) Amount beneficially owned: 1,230,000 -------------------------------------------------------------------- (b) Percent of class: 5.36% -------------------------------------------------------------------- (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 1,230,000 ---------------------- (ii) Shared power to vote or to direct the vote 0 -------------------- (iii) Sole power to dispose or to direct the disposition of 1,230,000 -------------------------------------------------------------- (iv) Shared power to dispose or to direct the disposition of 0 ------- Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the Beneficial owner of more than five percent of the class of securities, check the following | |. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable ------------------------- ---------------------------- CUSIP NO. 29664R106 13G Page 5 of 5 Pages ------------------------- ---------------------------- Item 10. Certification. By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true and correct. September 28, 2001 ------------------------------------------ (Date) ------------------------------------------ Scott Sacane